WallStreetZenWallStreetZen

NYSE: RCUS
Arcus Biosciences Inc Stock Ownership - Who owns Arcus Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcus Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Juan C. JaenPresident2026-01-0529,670$21.34
$633.16kSell
Juan C. JaenPresident2026-01-052,053$22.34
$45.86kSell
Juan C. JaenPresident2026-01-05100$23.20
$2.32kSell
Ii Robert C. GoeltzChief Financial Officer2025-12-316,552$23.38
$153.19kSell
Alexander AzoyChief Accounting Officer2025-12-184,343$22.25
$96.61kSell
Alexander AzoyChief Accounting Officer2025-12-172,113$22.16
$46.82kSell
Carolyn C. TangGeneral Counsel2025-12-176,810$22.16
$150.91kSell
Jennifer JarrettChief Operating Officer2025-12-179,983$22.16
$221.22kSell
Richard MarkusChief Medical Officer2025-12-174,494$22.16
$99.59kSell
Terry J. RosenChief Executive Officer2025-12-1725,744$22.16
$570.49kSell

1 of 5

RCUS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCUS insiders and whales buy or sell their stock.

RCUS Shareholders

What type of owners hold Arcus Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc29.10%31,424,760$722.46MInsider
Gilead Sciences Inc29.10%31,424,760$722.46MInstitution
Terry J. Rosen13.35%14,413,895$331.38MInsider
Blackrock Inc10.94%11,810,866$271.53MInstitution
Vanguard Group Inc6.14%6,629,453$152.41MInstitution
Point72 Asset Management LP4.01%4,332,479$99.60MInstitution
Woodline Partners LP3.49%3,769,684$86.67MInstitution
Suvretta Capital Management LLC3.42%3,688,858$84.81MInstitution
State Street Corp3.14%3,394,854$78.05MInstitution
Gv 2016 GP LLC2.89%3,125,312$71.85MInsider

1 of 3

RCUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCUS64.14%35.86%Net BuyingNet Selling
RARE85.64%14.36%Net SellingNet Selling
RXRX62.25%13.28%Net SellingNet Selling
MESO0.28%0.00%
IMNM92.03%7.97%Net BuyingNet Selling
View Top Biotech Stocks

Arcus Biosciences Stock Ownership FAQ

Who owns Arcus Biosciences?

Arcus Biosciences (NYSE: RCUS) is owned by 93.18% institutional shareholders, 52.10% Arcus Biosciences insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Arcus Biosciences shareholder, owning 31.42M shares representing 29.10% of the company. Gilead Sciences Inc's Arcus Biosciences shares are currently valued at $681.92M.

If you're new to stock investing, here's how to buy Arcus Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.